137 related articles for article (PubMed ID: 20676829)
1. Clinical-pathological conference: case 3.
Hall JM; Torske KR; Kahn MA; Moreland AA; Moschella SL
Head Neck Pathol; 2010 Sep; 4(3):226-9. PubMed ID: 20676829
[No Abstract] [Full Text] [Related]
2. [New WHO recommendations for the treatment of leprosy].
Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754
[No Abstract] [Full Text] [Related]
3. World Health Organization (WHO) antibiotic regimen against other regimens for the treatment of leprosy: a systematic review and meta-analysis.
Lazo-Porras M; Prutsky GJ; Barrionuevo P; Tapia JC; Ugarte-Gil C; Ponce OJ; Acuña-Villaorduña A; Domecq JP; De la Cruz-Luque C; Prokop LJ; Málaga G
BMC Infect Dis; 2020 Jan; 20(1):62. PubMed ID: 31959113
[TBL] [Abstract][Full Text] [Related]
4. OFLOXACIN multicentre trial in MB leprosy FUAM-Manaus and ILSL-Bauru, Brazil.
Cunha Mda G; Virmond M; Schettini AP; Cruz RC; Ura S; Ghuidella C; Viana Fdos R; Avelleira JC; Campos AA; Filho B
Lepr Rev; 2012 Sep; 83(3):261-8. PubMed ID: 23356027
[TBL] [Abstract][Full Text] [Related]
5. Case Report: A Case of Type 1 Leprosy Reaction and Dapsone Hypersensitivity Syndrome Complicating the Clinical Course of Multibacillary Leprosy.
Craig J; MacRae C; Melvin RG; Boggild AK
Am J Trop Med Hyg; 2019 May; 100(5):1145-1148. PubMed ID: 30915953
[TBL] [Abstract][Full Text] [Related]
6. Effect of treatment on PCR positivity in multibacillary leprosy patients treated with conventional and newer drugs ofloxacin and minocycline.
Singh HB; Katoch K; Natrajan M; Sharma RK; Gupta UD; Sharma VD; Singh D; Chauhan DS; Srivastava K; Katoch VM
Acta Leprol; 1999; 11(4):179-82. PubMed ID: 10987049
[TBL] [Abstract][Full Text] [Related]
7. Is drug-resistant Mycobacterium leprae a real cause for concern?: First approach to molecular monitoring of multibacillary Colombian patients with and without previous leprosy treatment.
Guerrero MI; Colorado CL; Torres JF; León CI
Biomedica; 2014 Apr; 34 Suppl 1():137-47. PubMed ID: 24968045
[TBL] [Abstract][Full Text] [Related]
8. Leprosy treatment during pregnancy and breastfeeding: A case report and brief review of literature.
Ozturk Z; Tatliparmak A
Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27549245
[TBL] [Abstract][Full Text] [Related]
9. Tenosynovitis: An unusual presentation of leprosy.
Baveja S; Bisht PB; Sood A
Int J Mycobacteriol; 2017; 6(2):196-198. PubMed ID: 28559526
[TBL] [Abstract][Full Text] [Related]
10. Leprosy in transplant recipients: report of a case after liver transplantation and review of the literature.
Trindade MA; Palermo ML; Pagliari C; Valente N; Naafs B; Massarollo PC; D'Albuquerque LA; Benard G
Transpl Infect Dis; 2011 Feb; 13(1):63-9. PubMed ID: 20678090
[TBL] [Abstract][Full Text] [Related]
11. Large infiltrated erythematous and scaly plaque on the cheek and thickened earlobe.
Gomez-Moyano E; Crespo-Erchiga A; Sanz-Trelles A; Vera-Casaño A; Fajardo FS; Iglesia JM; Crespo-Erchiga V
Clin Infect Dis; 2010 Apr; 50(7):1015-6, 1068-9. PubMed ID: 20201669
[No Abstract] [Full Text] [Related]
12. Long term follow-up results of 1 year MDT in MB leprosy patients treated with standard MDT + once a month Minocycline and Ofloxacin.
Katoch K; Katoch VM; Natarajan M; Gupta UD; Sharma VD; Singh HB
Indian J Lepr; 2008; 80(4):331-44. PubMed ID: 20329382
[TBL] [Abstract][Full Text] [Related]
13. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
Mane I; Cartel JL; Grosset JH
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
[TBL] [Abstract][Full Text] [Related]
14. Multibacillary Mid-Borderline Leprosy with Type 1 Lepra Reaction and Concurrent Latent Tuberculosis.
Chew R; Woods ML
Am J Trop Med Hyg; 2021 Oct; 106(2):373-375. PubMed ID: 34695791
[No Abstract] [Full Text] [Related]
15. Single dose ROM therapy in Goa.
Shukla P; Miranda MS; Prabhudesai R; Rege VL
Indian J Lepr; 2002; 74(2):169-72. PubMed ID: 12708738
[No Abstract] [Full Text] [Related]
16. Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up.
Ganapati R; Revankar CR; Pai VV; Kingsley S
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):308-9. PubMed ID: 10575413
[No Abstract] [Full Text] [Related]
17. Single-dose treatment for paucibacillary leprosy; field implications.
Revankar CR; Pai VV; Samy MS; Ganapati R
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):312-4. PubMed ID: 10575415
[No Abstract] [Full Text] [Related]
18. Single-dose treatment for paucibacillary leprosy; clinical problems and management.
Pai VV; Bulchand HO; Revankar CR; Ganapati R
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):310-2. PubMed ID: 10575414
[No Abstract] [Full Text] [Related]
19. Rifampicin/minocycline and ofloxacin (ROM) for single lesions--what is the evidence?
Lockwood DN
Lepr Rev; 1997 Dec; 68(4):299-300. PubMed ID: 9503865
[No Abstract] [Full Text] [Related]
20. Single dose multidrug therapy for single lesion paucibacillry leprosy.
Salafia A
Indian J Lepr; 1998; 70(2):216-9; author reply 219-21. PubMed ID: 9724861
[No Abstract] [Full Text] [Related]
[Next] [New Search]
